A. N. Cayley et al. / Tetrahedron Letters 48 (2007) 6556–6560
6559
i. HATU, DIPEA
O
H
N
DCM, 0 oC - rt, 2 h
HO
O
O
+
+
Ph
Ph
HO
NH2
ii. Filtration
iii. SnCl2.2H2O, DCM, rt, 12 h
O
O
14a
13a
11a
(α:β = 2:1)
43% (separable)
i. HATU, DIPEA
DCM, 0 oC - rt, 2 h
Boc
H
O
BocHN
HO
N
O
Me
Me
N
NH2
ii. Filtration
iii. SnCl2.2H2O, DCM, rt, 12 h
O
O
13a
14b
11b
(α:β = 1:3)
55% (inseparable)
i. HATU, DIPEA
H
O
O
DCM, 0 oC - rt, 2 h
HO
+
O
HO
N
NHBoc
ii. Filtration
NHBoc
NH2
iii. SnCl2.2H2O, DCM, rt, 24 h
O
O
11c
13a
14c
46%
i. HATU, DIPEA
DCM, 0 oC - rt, 2 h
O
HO
O
O
HO
N
NH2
ii. Filtration
O
iii. SnCl2.2H2O, DCM, rt, 20 h
O
13a
14d
11d
45%
Scheme 5.
65–76, but this employed hydrochloric acid and was far
less efficient; For a related procedure using tosic acid see:
(c) Ijzendoorn, D. R.; Botman, P. N. M.; Blaauw, R. H.
Org. Lett. 2006, 8, 239–242; See also: (d) Armorde, S. M.;
Judd, A. S.; Martin, S. F. Org. Lett. 2005, 7, 2031–2033.
7. Han, J. L.; Ong, C. W. Tetrahedron 2007, 63, 609–614.
8. For similar systems see: Meyers, A. I.; Lefker, B. A.;
Sowin, T. J.; Westrum, L. J. J. Org. Chem. 1989, 54, 4243–
4246.
well as extending the range of the procedure and inves-
tigating its application to complex natural product
targets.
Acknowledgements
We are grateful to the University of York for student-
ship/PDRA support (J.P.S., A.C.), AstraZeneca for
9. Shea, K. J.; Wada, E. J. Am. Chem. Soc. 1982, 104, 5715–
5719.
`
additional funding (J.P.S.) and the French Ministere
10. All novel compounds were fully characterised by their
1H/13C NMR, IR and HRMS or elemental analysis.
11. Other coupling agents were also investigated: with pro-
pane phosphonic acid anhydride (T3Pꢁ) a 41% overall
yield was obtained; when HATU was employed the amide
coupling step was unsuccessful.
`
des Affaires Etrangeres for a Lavoisier Postdoctoral
Fellowship (C.M.M.).
References and notes
12. Representative procedure: Methyl 3R,7aS-5-oxohexahy-
dropyrrolo[2,1-b]thiazole-3-carboxylate (7a). (a) Isobutyl
chloroformate (44 lL, 0.34 mmol) was added dropwise to
a solution of acid 9a9 (50 mg, 0.34 mmol) and N-meth-
ylpiperidine (41 lL, 0.34 mmol) in DCM (4 mL) at
ꢁ10 ꢂC. After 2 min, an ice cold solution of L-cysteine
methyl ester hydrochloride 10a (62 mg, 0.36 mmol) and N-
methylpiperidine (44 lL, 0.36 mmol) in DCM (1 mL) was
added dropwise and stirring continued at ꢁ10 ꢂC for 1 h
and then at rt for a further 1 h. The solution was then
filtered through a short pad of silica gel, washing through
with EtOAc (3 · 5 mL) and the volatiles removed from the
filtrate in vacuo to give the crude amide 8a, which was
used immediately without further purification; (b) Unpu-
rified amide 8a was re-dissolved in DCM (5 mL). Stannous
chloride dihydrate (Aldrich 20803-5, 0.17 g, 0.75 mmol)
1. Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev.
2003, 103, 893–930, and references cited therein.
2. Faul, M. M. In Encyclopedia of Reagents for Organic
Synthesis; Paquette, L. A., Ed.; John Wiley: Chichester,
1995; Vol. 7, pp 4892–4896.
3. Ford, K. L.; Roskamp, E. J. Tetrahedron Lett. 1992, 33,
1135–1138.
4. Foot, J. S.; Giblin, G. M. P.; Taylor, R. J. K. Org. Lett.
2003, 5, 4441–4444.
´
5. Menard-Moyon, C.; Taylor, R. J. K. Eur. J. Org. Chem.
2007, 3698–3706.
6. (a) Reid, M.; Taylor, R. J. K. Tetrahedron Lett. 2004, 45,
4181–4183; It should be noted that a similar cyclisation
was first reported by Winterfeld et al.: (b) Winterfeld, K.;
Michael, H. Arch. Pharm. Ber. Dtsch. Pharm. Ges. 1961,